Showing results (171-180 of 219) with videos related to
Sort By:
Pageof 22
BMC Microbiology|July 17, 2016
E2 multimeric scaffold for vaccine formulation: immune response by intranasal delivery and transcriptome profile of E2-pulsed dendritic cellsMaria Trovato, Francesco Maurano, Luciana D'Apice, et al.Blood Advances|October 9, 2020
Tumor burden, inflammation, and product attributes determine outcomes of axicabtagene ciloleucel in large B-cell lymphomaFrederick L Locke, John M Rossi, Sattva S Neelapu, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 14, 2020
A Phase I, Open-label, Dose-escalation, and Cohort Expansion Study to Evaluate the Safety and Immune Response to Autologous Dendritic Cells Transduced With AdGMCA9 (DC-AdGMCAIX) in Patients With Metastatic Renal Cell CarcinomaIzak Faiena, Begoña Comin-Anduix, Beata Berent-Maoz, et al.Journal of Surgical Oncology|June 2, 2004
Pelvic exenteration and sphincter preservation: an analysis of 96 casesAntonio Henrique Oliveira Poletto, Ademar Lopes, André Lopes Carvalho, et al.Frontiers in Oncology|April 4, 2022
Breast Cancer Phenotype Associated With Li-Fraumeni Syndrome: A Brazilian Cohort Enriched by <i>TP53</i> p.R337H CarriersRenata Lazari Sandoval, Natalia Polidorio, Ana Carolina Rathsam Leite, et al.The Journal of Clinical Investigation|July 26, 2022
Multidimensional single-cell analysis identifies a role for CD2-CD58 interactions in clinical antitumor T cell responsesGabrielle Romain, Paolo Strati, Ali Rezvan, et al.Journal of Translational Medicine|November 7, 2012
A novel series of conferences tackling the hurdles confronting the translation of novel cancer immunotherapiesAdrian Bot, Mark Ahn, Marnix Bosch, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2009
Lymph node-targeted immunotherapy mediates potent immunity resulting in regression of isolated or metastatic human papillomavirus-transformed tumorsKent A Smith, Brenna L Meisenburg, Victor L Tam, et al.Familial Cancer|April 30, 2024
A comprehensive characterization of the spectrum of MUTYH germline pathogenic variants in Latin AmericaPatricia Esperon, Florencia Neffa, Walter Pavicic, et al.Nature Medicine|April 16, 2020
Author Correction: Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphomaJennifer N Brudno, Norris Lam, Danielle Vanasse, et al.Pageof 22